FDA Adverse Event Other Summary report: N

RADIESSE DERMAL FILLER

MDR report key: 2111506 · Received May 20, 2011

Report

Report Number
2135225-2011-00033
Event Type
Other
Date Received
May 20, 2011
Date of Event
April 6, 2011
Report Date
April 11, 2011
Manufacturer
MERZ AESTHETICS, INC.
Product Code
LMH
PMA / PMN Number
P050052
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NV, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE PT'S SYMPTOMS HAD RESOLVED AT THE TIME THIS EVENT WAS REPORTED TO MERZ AESTHETICS. DR (B)(6) REQUESTED INFO ABOUT THE COMPOSITION OF RADIESSE AND REQUESTED A SAMPLE FOR ALLERGY SKIN TESTING. DR (B)(6) PLANS TO TEST THE PT FOR RADIESSE ALLERGY STARTING ON (B)(6). A F/U REPORT IS EXPECTED, WITH RESULTS FROM THE RADIESSE ALLERGY TESTING. SINCE DR (B)(6) WAS NOT THE RADIESSE INJECTOR, THE INJECTION DETAILS ARE NOT AVAILABLE, I.E. RADIESSE LOT NUMBER, AMOUNT INJECTED, AREAS INJECTED OR INJECTION DATE.

Description of Event or Problem · 1

A (B)(6) FEMALE PT HAD BEEN INJECTED WITH RADIESSE DERMAL FILLER; FACIAL AREAS NOT IDENTIFIED AND DATE OF INJECTION IS UNK, BUT OCCURRED IN 2011. AT 7 DAYS POST INJECTION, THE PT DEVELOPED SEVERE FACIAL EDEMA. THE PT WAS HOSPITALIZED FOR ONE WEEK, TREATED WITH ANTIBIOTICS, AND THE EDEMA RESOLVED. TREATING PHYSICIAN, DR (B)(6), INDICATED THAT HE FEELS THIS PT HAD AN ALLERGIC REACTION, NOT CELLULITIS AS HOW SHE HAD BEEN TREATED. THE PT DID HAVE A FEVER (AFEBRILE) AND HAD A NORMAL WHITE BLOOD CELL COUNT. DR (B)(6) REQUESTED INFO ABOUT THE COMPOSITION OF RADIESSE; WHICH WAS PROVIDED TO HIM ON (B)(6) 2011.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 RADIESSE DERMAL FILLER INJECTABLE IMPLANT LMH MERZ AESTHETICS, INC. UNK

Patients

Seq Age Sex Outcome Treatment
1 45 YR Hospitalization